DUBLIN, Ireland — The shareholders of Elan Corp. plc have approved the company’s acquisition by Perrigo Co.
Ireland-based Elan said Monday that the approval came via two special meetings of shareholders: a special court-ordered meeting and an extraordinary general meeting. In both meetings, the shareholder votes were virtually unanimous in favor the agreement.
The pharmaceutical companies announced the $8.6 billion deal in late July.
Plans call for Allergan, Mich.-based Perrigo to acquire Elan by means of a scheme of arrangement under Irish law. A new holding company incorporated in Ireland will be formed and acquire Elan in a stock-and-cash transaction.
Pending the approval of the Irish High Court, the transaction is expected to close by the year’s end.
